CoChat

The safety and efficacy of remimazolam tosylate combined with propofol in upper gastrointestinal endoscopy: A multicenter, randomized clinical trial

Open access

Published version of a preprint

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

Introduction: Hypotension is the most common adverse event under propofol-mediated sedation and is possible to cause varying degrees of damage to patients. Whereas remimazolam has a poorer sedative effect than propofol. Aim: The aim of this study was to explore the advantages of the combination of remimazolam tosylate and propofol. Methods: 304 patients were divided into the remimazolam tosylate group (RT group), the propofol group (P group), and the remimazolam tosylate plus propofol group(R+T group). The primary outcome was the incidence of hypotension. Secondary outcomes included the results of sedation and recovery. The safety results mainly include the incidence of Hypotension, adverse respiratory events, postoperative nausea and vomiting, hiccup, cough, body movement and bradycardia. Results: The incidence of hypotension was 56.7% in the P group, 12.6% in the RT group, and 31.3% in the R+P group, three groups of pairwise comparisons showed statistical differences, with P < 0.001. The incidence of body movement was significantly higher in the RT group (26.1%) than in the P group (10.3%) and the R+P group (12.5%), P = 0.004. The endoscopist satisfaction was higher in the P (3.87±0.44) and R+P (3.95±0.22)groups than in the RT(3.53±0.84) group. The incidence of adverse events, in descending order, was P group, RT group, and R+P group (93.8%vs.61.3%vs.42.7%). Conclusion: Co-administration had fewer adverse events than propofol monotherapy, also had a better sedative effect and higher endoscopist satisfaction than remimazolam monotherapy. Trial registration: Clinical trial registration number: NCT05429086 .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0282930

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Consolidated standards of reporting trials (CONSORT) 2010 flow diagram of patients’ distribution.
Fig 1 Consolidated standards of reporting trials (CONSORT) 2010 flow diagram of patients’ distribution.CC BY · PubMed Central
Fig 2 Duration of blood pressure decrease. RT represents the Remimazolam tosylate group, P represents the propofol group, RT+P represents the Remimazolam combined with propofol group.
Fig 2 Duration of blood pressure decrease. RT represents the Remimazolam tosylate group, P represents the propofol group, RT+P represents the Remimazolam combined with propofol group.CC BY · PubMed Central
Fig 3 Mean MOAA/S score. RT represents the remimazolam tosylate group, P represents the propofol group, RT+P represents the remimazolam combined with propofol group.
Fig 3 Mean MOAA/S score. RT represents the remimazolam tosylate group, P represents the propofol group, RT+P represents the remimazolam combined with propofol group.CC BY · PubMed Central
Fig 4 Modified bromage score and head-up assessment. RT represents the remimazolam tosylate group, P represents the propofol group, RT+P represents the remimazolam combined with propofol group. The lower the grade, the higher the quality of patient recovery.
Fig 4 Modified bromage score and head-up assessment. RT represents the remimazolam tosylate group, P represents the propofol group, RT+P represents the remimazolam combined with propofol group. The lower the grade, the higher the quality of patient recovery.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 36

Metadata

Authors
Wei, A., Ma, S., Dou, Y., Wang, X., Wu, J., Zhou, S., Deng, Y., Liu, X., Li, D., & Yang, M.
Affiliations
University of Electronic Science and Technology of China (CN)
Corresponding author
Yang, Mengchang
Venue
PLOS ONE
Published
2023-08-03
Volume
18
Issue
8
Pages
e0282930
ISSN
1932-6203 (ISSN-L)
OpenAlex
W4385516506
Cited by
33
References
39
Citations by year
2026: 7 · 2025: 14 · 2024: 12
FWCI
10.75
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • medRxiv (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
  • Health Sciences › Veterinary › Small Animals › Veterinary Pharmacology and Anesthesia
  • Health Sciences › Medicine › Surgery › Nausea and vomiting management
Keywords
propofol, procedural sedation, upper gastrointestinal endoscopy, hypotension, sedation safety, sedation efficacy, respiratory adverse events, endoscopist satisfaction
MeSH terms
Benzenesulfonates, Benzodiazepines, Humans, Hypnotics and Sedatives, Hypotension, Propofol, Endoscopy, Gastrointestinal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.